Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q3 2025 Earnings Call Transcript
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q3 2025 Earnings Call Transcript November 6, 2025 Amylyx Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.37, expectations were $-0.43. Operator: Good morning. My name is Carly, and I will be …